“Latest Stem Cells News”

Stem cell therapy holds promise for the treatment of almost all human diseases, from spinal cord injuries to damage caused by heart attacks. Stem cells are the cells in our body that have the potential to “grow up” to be any type of cell in the body. But organs are more than just collections of cells. They’re highly organized collections of a multitude of cells.

All treatments with stems cells are still experimental, and therefore the risks of this treatment are not completely understood. Clinical trials are monitored in the United States by academic and government agencies to help protect research subjects. We are not familiar with the safety measures in place to protect research subjects in the Dominican Republic, and I am unaware of a stem cell pulmonary hypertension protocol in the Dominican Republic. Information about research protocols from around the world and information on how to enroll in such a trial can be found at http://clinicaltrials.gov.

from USnews

Another congestive heart failure patient has been helped by stem cell research using adult stem cells. Terry Areford, 62, a multiple heart attack victim has been given a 2nd chance at life after receiving Vescell stem cell treatment to heal his heart muscle in Thailand.

Congestive Heart Failure Symptoms

Terry was dying. He was slowing down. He had the usual symptoms of congestive heart failure. He had shortness of breath. He could barely walk 50 feet slowly. However, Terry still had hope. His daughter came across the Vescell website and contacted them.

Adult Stem Cells From Your Own Blood

For those of you unfamiliar with Vescell stem cell therapy in Thailand, it is a process created by a company called Theravitae in which adult stem cells are removed from the patient’s blood (similar to a blood donation) and then multiplied into a therapeutic dose and then implanted into the patient’s heart muscle and/or coronary arteries.

But back to Terry’s stem cell story-

Before Vescell Treatment

• Ejection Fraction 10%
• Could barely walk
• Severe shortness of breath

After Adult Stem Cells Implanted

• Ejection Fraction at 45%
• Plays 3 rounds of golf per week
• No shortness of breath- outside chopping firewood

3 full 18 hole rounds of golf per week? No kidding Terry?  I am very happy for you.   Like many of the Vescell heart patients recently, Terry has become an adult stem cell advocate and wants other congestive heart failure patients to know that there is still hope out there.

You are welcome to call or email Terry  at 304-594-9377 or his email is bkareford@msn.com

Stem Cell Research in Thailand

This is the third stem cell research success story to come out of Thailand in the last month. See stories from heart attack victims and heart failure patients James Eilert and Andy Jordan as well.   Is anyone in the FDA paying attention to this?  Adult Stem Cells can be used now to help these heart patients with no side effects!  Why do they have to leave the United States for it?

In the Dominican Republic, Dr. Zannos Grekos, a stem cell research doctor, is now helping patients with heart disease and lung diseases with their own Adult Stem Cells as reported on CNN in a special research report.

Adult Stem Cells Helping Heart Disease and Lung Disease

In the last 18 months, Dr. Grekos and his company Regenocyte have treated more than 100 patients for either heart diseases such as congestive heart failure, coronary artery disease, heart attacks, and angina and lung diseases such as pulmonary hypertension, emphysema and COPD.

The story features Barbara McKean of Naples, Florida. Barbara was suffering from the lung disease, COPD and was treated with her own stem cells.

From the stem cell article:
“Right away, the next morning, I felt a sense of well-being that I hadn’t felt in a long, long time,” McKean said.

“I know that I am living proof that this does work,” she added. “I know that.”

His Eyes Are Wide Shut

Check out this quote from the chief medical officer of the American Lung Association-

The chief medical officer of the American Lung Association, Dr. Norman Edelman, said he does not doubt the sincerity of patients who believe they have been helped by stem cell therapy. But he added, “There’s an enormous placebo effect in almost all of these cases.”

So Dr. Edelman sees a woman, Barbara McKean, featured previously here,  who was on oxygen 24/7 walking around with a cannister and now, after stem cell treatment, is completely off oxygen and he thinks it is the placebo effect? Ridiculous.

Luckily, Barbara’s doctor does not intentionally close his eyes to the obvious:

McKean’s family physician, Dr. Robert Folsom, confirmed to CNN that she had been suffering for many years from an advanced state of COPD, an incurable lung disease. Folsom told CNN he was “quite incredulous” after seeing her condition improve.

Folsom, who said he has been McKean’s family physician for many years, disputed any suggestion that her apparent recovery stemmed from a “placebo effect” — an improvement sometimes seen in patients who are given an inert substance in clinical trials.

“I know about the placebo effect, and her improvement does not seem to be a result of that,” he said.

Stem Cell Therapy- Documenting Results

Dr. Grekos is documenting research data  from his patients treated with their own stem cells and wishes to present it to the FDA at the end of this year.

In the past few days, another stem cell research doctor, Dr. Roberto Fernandez Vina, also just presented his results of his stem cell research data for COPD and Emphysema at the annual International Society for Stem Cell Research annual meeting.

And Dr. Grekos had a parting shot for the “experts” who always try to downplay any adult stem cell success story:

He shrugs off the criticism from people who doubt his claims, saying he — and not they — are on medicine’s cutting edge.

Stem cell experts who reject his methods “need to be better educated,” he said.

original post by Don Margolis

Concha Herrera Arroyo, from El Pais

The Cardiology department and the Area of Cell Therapy of Cordoba hospital Reina Sofia are carrying out clinical tests with patients who have suffered from a severe heart attack. With the implantation of the patient’s stem cells, the heart regenerates thus improving its wall motion, that is, its cardiac performance.

Indeed for the last four years, the Area of Cell Therapy of Cordoba hospital, led by haematologist Dr. Concha Herrera, has been implementing a therapy program with adult stem cells in patients with heart-related problems. However, this therapy is not a service the hospital offers yet. More specifically, at the end of 2007 the hospital ended a clinical test with patients who had suffered a severe myocardial infarction, that is, an obstruction of one of the main coronary arteries that stops the blood pump to the heart.

The test consisted of treating 30 people split into three groups of ten each at random. The first group was the control group, where patients received standard treatment for acute myocardial infarction; the second group was treated with stem cells directly implanted into the coronary artery affected using a catheterization; the third group was treated with a medicine called G-CSF, which makes cells move from the marrow to the blood, so that they get to the heart in a natural way, without having to do so through a catheter.

At the end of the test, the results revealed that the two groups treated without cells improved slightly, whereas patients transplanted with stem cells through the coronary arteries (vessels which bring the blood to the Herat muscle) did improve their ventricular function much more. This was interpreted as a significant decrease of the cardiac failure symptoms such as pain, fatigue and breathlessness when making small efforts.

Moreover, with this process it is possible to prevent some acute arrhythmias (change or irregularity in the rhythm of the heartbeat), which in many cases could result in the patient’s death. ‘However, it does not prevent a future heart attack’, Dr. Herrera assures.

In short, the stem cells transplanted from the marrow into the heart muscle have a double function: on the one hand they regenerate the heart cells, the cardiomiocites. In addition to this, they segregate a series of proangiogenic factors that produce blood vessels (angiogenesis) and can also produce the recruitment of stem cells that are in the myocardium itself.

For patients who suffer a major heart attack, get treatment at the hospital but are left with a damaged heart, Dr. Roger Gammon of the Heart Hospital of Austin is testing a new process to reverse that damage.

Just as a Houston hospital is investigating stem cells to repair the brains of stroke patients (see yesterday’s blog), the Heart Hospital is trying out a new stem cell therapy to fix the hearts of patients who suffered their first attack.
It is one of the nation’s first hospitals to test the new therapy.

Gammon, an interventional cardiologist, is leading the clinical trial in which patients are injected with donated adult stem cells from the bone marrow of others. The stems cells are purified by Osiris Therapeutics, Inc., which markets them as a product called Prochymal. Osiris is financing the research project, which is being done in the gold-standard way: Half of the patients are getting stem cells, and half are getting a placebo (a harmless product that looks the same). The researchers and patients don’t know which patients are getting the stem cells and which one aren’t.

Treating a heart attack with the patients’ own bone marrow stem cells boosts blood flow within the heart and may help reduce long-term complications, a new U.S. study finds.
The study included 31 patients who underwent angioplasty and stent placement after a heart attack. Within one week of the attacks, 16 of the patients received infusions of their own bone marrow cells into the coronary artery in which a blockage had caused the event.

The 16 patients received different amounts of bone marrow stem cells — 5 million, 10 million and 15 million cells. The 15 patients in the control group received standard medication only. All the patients were followed for up to five years.
After three to six months, patients who received higher doses of bone marrow stem cells showed greater improvement in blood flow within the heart than patients who received lower doses and those in the control group, the researchers said.